- Home
- ZVIA vs KRRO Comparison
ZVIA vs KRRO Comparison
Compare ZVIA & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZVIA
- KRRO
- Stock Information
- Founded
- ZVIA 2007
- KRRO 2014
- Country
- ZVIA United States
- KRRO United States
- Employees
- ZVIA N/A
- KRRO N/A
- Industry
- ZVIA Beverages (Production/Distribution)
- KRRO Biotechnology: Pharmaceutical Preparations
- Sector
- ZVIA Consumer Staples
- KRRO Health Care
- Exchange
- ZVIA Nasdaq
- KRRO Nasdaq
- Market Cap
- ZVIA 196.5M
- KRRO 209.6M
- IPO Year
- ZVIA 2021
- KRRO 2019
- Fundamental
- Price
- ZVIA $2.30
- KRRO $13.90
- Analyst Decision
- ZVIA Hold
- KRRO Strong Buy
- Analyst Count
- ZVIA 3
- KRRO 7
- Target Price
- ZVIA $2.58
- KRRO $106.33
- AVG Volume (30 Days)
- ZVIA 363.9K
- KRRO 110.5K
- Earning Date
- ZVIA 05-07-2025
- KRRO 05-13-2025
- Dividend Yield
- ZVIA N/A
- KRRO N/A
- EPS Growth
- ZVIA N/A
- KRRO N/A
- EPS
- ZVIA N/A
- KRRO N/A
- Revenue
- ZVIA $155,049,000.00
- KRRO $2,271,000.00
- Revenue This Year
- ZVIA $5.70
- KRRO N/A
- Revenue Next Year
- ZVIA $7.10
- KRRO $20.00
- P/E Ratio
- ZVIA N/A
- KRRO N/A
- Revenue Growth
- ZVIA N/A
- KRRO N/A
- 52 Week Low
- ZVIA $0.62
- KRRO $11.13
- 52 Week High
- ZVIA $4.99
- KRRO $98.00
- Technical
- Relative Strength Index (RSI)
- ZVIA 49.39
- KRRO 34.42
- Support Level
- ZVIA $2.21
- KRRO $12.21
- Resistance Level
- ZVIA $2.40
- KRRO $15.30
- Average True Range (ATR)
- ZVIA 0.15
- KRRO 2.09
- MACD
- ZVIA 0.05
- KRRO 0.21
- Stochastic Oscillator
- ZVIA 76.36
- KRRO 38.74
About ZVIA Zevia PBC
Zevia PBC is a beverage company disrupting the liquid refreshment beverage industry through refreshing, zero-calorie, zero-sugar, naturally sweetened beverages that are all Non-GMO Project Verified. It offers a platform of products that include a variety of flavors across Soda, Energy Drinks, Organic Tea, Mixers, Kidz drinks, and Sparkling Water. Its products are distributed across the U.S. and Canada through a network of retailers in the food, drug, mass, natural, and e-commerce channels. The company derives a majority of its revenue from the United States.
About KRRO Korro Bio Inc.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.